Objective: Surgical treatment of anal fi ssure can cause permanent incontinence in some patients. Topical medications have less adverse ef ects. Th e aim of this study was to compare the ef ectiveness of Diltiazem 2% topical with GTN 0.2% ointment in the treatment of chronic anal fi ssure with a view to establish which drug should be used as fi rst line in conservative management. Material and Methods: Th is randomized clinical trial was carried out in Department of Surgery, Distric Headquaters Hospital (DHQ), Abbot abad from April 2020 to February 2021. Patients with chronic anal fi ssure above 18 years of age were treated with Diltiazem 2% (34 patients) and GTN 0.2% (34 patients) in the anal canal three times a day for 6 weeks duration. Age, symptoms, gender, location of ulcer, healing rate and adverse ef ect like headache were compared. SPSS 17 was used for calculation. X2 test used for comparing healing rate and incidence of headache. P value below 0.05 considered signifi cant. Results: 68 patients were included in study. Th ey were randomly allocated to two groups. Group-A (Diltiazem DTZ) comprised of 34 patients while group-B (GTN) contained 34 patients. Dif erence between healing rates was not signifi cant between two groups. GTN group had more headache than DTZ group. Conclusion: Medical treatment is the initial treatment for chronic anal fi ssure. Both DTZ and GTN have comparable rate in healing chronic anal fi ssure although DTZ is superior to GTN in relation to headache.